GEN Exclusives

More »

GEN News Highlights

More »
Jul 24, 2012

Life Technologies Partners with SATuRN to Increase Access to HIV Testing in Africa

  • Life Technologies and the Southern African Treatment and Resistance Network (SATuRN) are collaborating on sequencing-based diagnostics for HIV-infected individuals in Africa.

    Though antiretroviral (ARV) drugs are becoming increasingly available in developing countries, resistance to these drugs occurs in many HIV-infected patients. Genetic sequencing of two viral genes can monitor resistance, but routine use is prohibitive in most African countries due to current costs.

    Life Technologies and SATuRN have developed an economical solution for ARV resistance testing which is being made available to African partners. The test can be run on Life's Applied Biosystems line of Sanger sequencing instruments, which are installed in a broad range of African hospitals and HIV-testing centers. SATuRN has collated over 7,000 resistance genotypes linked to treatment and clinical information. Its partnership with Life will allow more laboratories to use genotyping techniques, and large surveys on drug resistance to be produced to inform national department of health and policy makers in southern Africa.

    SATuRN currently includes 24 research and governmental partners. It has trained 1,315 physicians and medical personnel on the interpretation of HIV drug resistance in southern Africa. There are more than 2 million patients on ARV treatment in the region.

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Patient Access to Genetic Information

Do you think patients have the absolute right to gain access to their own genetic information from medical or clinical laboratories?

More »